Specialty Veterinary Pharmacy (SVPMEDS) offers Molnupiravir Capsules compounded for cats pursuant to patient-specific prescriptions from licensed veterinarians.
Molnupiravir, also known as EIDD-2801, is an antiviral compound that has been investigated in veterinary medicine, including research involving Feline Infectious Peritonitis (FIP). SVPMEDS compounds molnupiravir into oral capsules according to the prescribing veterinarian’s specified strength, quantity, and administration instructions.
Our pharmacy also offers Molnupiravir Oral Anhydrous Liquid, providing veterinarians with an alternative dosage form when a liquid preparation is preferred.
SVPMEDS prepares molnupiravir capsules according to individual veterinary prescriptions. Capsule formulations provide a solid oral dosage form for cats when the prescribing veterinarian determines that capsule administration is appropriate.
Features of the compounded preparation include:
SVPMEDS compounds molnupiravir capsules in a variety of strengths according to patient-specific veterinary prescriptions.
Veterinarians may contact our pharmacy team to discuss available capsule strengths and formulation options. The prescribing veterinarian determines the appropriate strength, administration schedule, and treatment duration for each patient.
Feline Infectious Peritonitis (FIP) is a serious disease associated with feline coronavirus infection. Diagnosis and management require veterinary evaluation, and treatment decisions depend on the individual cat’s clinical condition.
Veterinary research has examined several antiviral compounds in relation to FIP, including molnupiravir and GS-441524. These compounds differ in their pharmacology, clinical evidence, and safety considerations.
For general educational information about the disease, visit Feline Infectious Peritonitis at VeterinaryPartner (VIN).
External educational resources are provided for general information and do not constitute an endorsement or claim regarding the safety or effectiveness of SVPMEDS compounded preparations.
SVPMEDS prepares Molnupiravir Capsules using established nonsterile compounding procedures and pharmacy quality-control practices.
Our pharmacists follow applicable compounding standards and pharmacy procedures addressing ingredient verification, formulation, preparation, labeling, and dispensing.
Each prescription is prepared according to the prescribing veterinarian’s instructions and the pharmacy’s applicable quality-control requirements.
Molnupiravir Capsules should be administered only as directed by the prescribing veterinarian and according to the prescription label.
Important Handling Information: Individuals who are pregnant, may become pregnant, or are breastfeeding should consult the dispensing pharmacist and an appropriate healthcare professional about potential exposure and handling precautions.
SVPMEDS offers additional compounded antiviral formulations pursuant to patient-specific veterinary prescriptions.
SVPMEDS also compounds molnupiravir as an oral anhydrous liquid. This formulation provides an alternative to capsules when the prescribing veterinarian determines that a liquid dosage form is appropriate. Learn more about Molnupiravir Oral Anhydrous Liquid Compounded for Cats.
GS-441524 is a separate antiviral compound available from SVPMEDS in a compounded oral liquid formulation. Learn more about GS-441524 Flavored Oral Liquid for Cats.
SVPMEDS also compounds GS-441524 capsules according to patient-specific veterinary prescriptions. Learn more about GS-441524 Capsules for Cats.
Another available GS-441524 dosage form is a compounded flavored soft chewable. Learn more about GS-441524 Flavored Soft Chewables for Cats.
These products contain different active ingredients or use different dosage forms and should not be considered interchangeable without direction from the prescribing veterinarian.
SVPMEDS compounds Molnupiravir Capsules according to patient-specific prescriptions from licensed veterinarians. Each preparation is compounded based on the prescribed strength, quantity, and administration instructions.
Prescription Required: A valid prescription from a licensed veterinarian is required before this medication can be prepared and dispensed.
Compounded Medication: Molnupiravir Capsules are compounded preparations and are not FDA-approved animal drugs. Compounding and dispensing are subject to applicable federal and state requirements.
Molnupiravir Capsules are nonsterile compounded oral preparations containing molnupiravir, prepared according to patient-specific prescriptions from licensed veterinarians.
Molnupiravir and GS-441524 are different antiviral compounds. Both have been investigated in veterinary research involving FIP, but they differ in their pharmacology, safety considerations, and clinical evidence. The prescribing veterinarian determines which medication, if any, is appropriate for an individual patient.
SVPMEDS compounds molnupiravir capsules in individualized strengths according to veterinary prescriptions. Contact our pharmacy team to discuss available strengths and formulation requirements.
Capsules provide a solid oral dosage form as an alternative to liquid preparations. The prescribing veterinarian determines whether capsules are appropriate for the individual patient.
Capsules should not be opened, crushed, or divided unless specifically instructed by the dispensing pharmacist. Molnupiravir has important handling considerations, including potential exposure to the active ingredient.
Yes. SVPMEDS offers Molnupiravir Oral Anhydrous Liquid Compounded for Cats according to patient-specific veterinary prescriptions.
Yes. Molnupiravir has potential reproductive and genetic toxicity concerns. Caregivers should follow the handling instructions supplied by the pharmacy and consult the pharmacist regarding potential exposure risks.
Follow the storage instructions and beyond-use date on the prescription label. Contact SVPMEDS if additional guidance is needed.
No. Compounded Molnupiravir Capsules are not FDA-approved animal drugs.
Yes. A valid patient-specific prescription from a licensed veterinarian is required before SVPMEDS can prepare and dispense this medication.
Veterinarians and existing SVPMEDS customers can access the SVPMEDS Portal to submit patient-specific prescriptions and use available ordering services.
For questions about compounded molnupiravir capsule strengths, dosage forms, or prescription requirements, contact our pharmacy team.